This study aimed to investigate the influence of surgical intervention on recurrence risk of upper urinary tract stone and compare the medical burden of various surgical procedures.
This study analyzed data from patients with upper urinary tract stone extracted from a national database of hospitalized patients in China, from January 2013 to December 2018. Surgical recurrence was defined as patients experience surgical procedures for upper urinary tract stone again with a time interval over 90 days. Associations of surgical procedures with surgical recurrence were evaluated by Cox regression.
In total, 556,217 patients with upper urinary tract stone were included in the present analysis. The mean age of the population was 49.9 ± 13.1 years and 64.1% were men. During a median follow-up of 2.7 years (IQR 1.5-4.0 years), 23,012 patients (4.1%) had surgical recurrence with an incidence rate of 14.9 per 1000 person-years. Compared to patients receiving open surgery, ESWL (HR, 1.59; 95% CI 1.49-1.70), URS (HR, 1.38; 95% CI 1.31-1.45), and PCNL (HR, 1.11; 95% CI 1.06-1.18) showed a greater risk for surgical recurrence. Patients receiving ESWL had the shortest hospital stay length and the lowest cost among the 4 procedures.
Compared with open surgery, ESWL, URS, and PCNL are associated with higher risks of surgical recurrence for upper urinary tract stone, while ESWL showed the least medical burden including both expenditure and hospital stay length. How to keep balance of intervention efficacy and medical expenditure is an important issue to be weighed cautiously in clinic practice and studied more in the future.
World journal of urology. 2024 Mar 13*** epublish ***
Qin Wang, Yu Wang, Chao Yang, Jinwei Wang, Xiao-Chun Zhang, Luxia Zhang, Ming-Hui Zhao
Renal Division, Department of Medicine, Institute of Nephrology, Peking University First Hospital, Peking University, 8 Xishiku Street, Xicheng District, Beijing, 100034, China., Renal Division, Department of Medicine, Institute of Nephrology, Peking University First Hospital, Peking University, 8 Xishiku Street, Xicheng District, Beijing, 100034, China. ., Department of Urology, Institute of Urology, Peking University First Hospital, National Urological Cancer Center, Peking University, 8 Xishiku Street, Xicheng District, Beijing, 100034, China. .